Lv4
470 积分 2024-07-12 加入
NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024
1天前
待确认
Rare vulvar malignancies; incidence, treatment and survival in the Netherlands
3天前
求助中
原发阴道、外阴恶性黑色素瘤的临床特征分析
16天前
已完结
Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study
5个月前
已完结
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial
5个月前
已完结
Clinical management of gastrointestinal and liver toxicities of immune checkpoint inhibitors
6个月前
已完结
A Systematic Review and Meta-Analysis of Endocrine-Related Adverse Events Associated with Immune Checkpoint Inhibitors
6个月前
已完结
Clinical associations and classification of immune checkpoint inhibitor-induced cutaneous toxicities: a multicentre study from the European Academy of Dermatology and Venereology Task Force of Dermatology for Cancer Patients
6个月前
已完结
Epidemiology and risk factors for the development of cutaneous toxicities in patients treated with immune-checkpoint inhibitors: A United States population-level analysis
6个月前
已完结
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
6个月前
已完结
皖公网安备34019202002308
